Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Carson

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Circulation|December 1, 1994
Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST)J L Anderson, E V Platia, A Hallstrom, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1973
A quinoline methanol (WR 30090) for treatment of acute malariaD C Martin, J D Arnold, D F Clyde, et al.
Science (New York, N.Y.)|November 21, 1975
Mefloquine (WR 142,490) in the treatment of human malariaC M Trenholme, R L Williams, R E Desjardins, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1973
A phenanthrene methanol (WR 33063) for treatment of acute malariaJ D Arnold, D C Martin, P E Carson, et al.
The Journal of Laboratory and Clinical Medicine|April 1, 1987
Biotransformation of primaquine in vitro with human K562 and bone marrow cellsH Frischer, T Ahmad, M V Nora, et al.
American Journal of Physical Anthropology|May 1, 1971
Hemoglobin and red cell enzyme variation in some populations of the Republic of Vietnam with comments on the malria hypothesisJ E Bowman, P E Carson, H Frischer, et al.
The New England Journal of Medicine|July 15, 1993
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study GroupA M Feldman, M R Bristow, W W Parmley, et al.
The American Journal of Cardiology|October 22, 1998
Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival EvaluationC M O'Connor, P E Carson, A B Miller, et al.
The New England Journal of Medicine|October 10, 1996
Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study GroupM Packer, C M O'Connor, J K Ghali, et al.
Journal of the American College of Cardiology|February 14, 1998
Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research InvestigatorsD R Ferry, R A O'Rourke, A S Blaustein, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Circulation|December 1, 1994
Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST)J L Anderson, E V Platia, A Hallstrom, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1973
A quinoline methanol (WR 30090) for treatment of acute malariaD C Martin, J D Arnold, D F Clyde, et al.
Science (New York, N.Y.)|November 21, 1975
Mefloquine (WR 142,490) in the treatment of human malariaC M Trenholme, R L Williams, R E Desjardins, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1973
A phenanthrene methanol (WR 33063) for treatment of acute malariaJ D Arnold, D C Martin, P E Carson, et al.
The Journal of Laboratory and Clinical Medicine|April 1, 1987
Biotransformation of primaquine in vitro with human K562 and bone marrow cellsH Frischer, T Ahmad, M V Nora, et al.
American Journal of Physical Anthropology|May 1, 1971
Hemoglobin and red cell enzyme variation in some populations of the Republic of Vietnam with comments on the malria hypothesisJ E Bowman, P E Carson, H Frischer, et al.
The New England Journal of Medicine|July 15, 1993
Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study GroupA M Feldman, M R Bristow, W W Parmley, et al.
The American Journal of Cardiology|October 22, 1998
Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival EvaluationC M O'Connor, P E Carson, A B Miller, et al.
The New England Journal of Medicine|October 10, 1996
Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study GroupM Packer, C M O'Connor, J K Ghali, et al.
Journal of the American College of Cardiology|February 14, 1998
Design and baseline characteristics of the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. VANQWISH Trial Research InvestigatorsD R Ferry, R A O'Rourke, A S Blaustein, et al.
Pageof 5